|
|||
On the basis of hospital discharge data, the frequency of neonatal HSV infection in the United States varies
Pathophysiology
Diagnosis
Manifestations of Neonatal HSV Infection
Treatment of Neonatal HSV Infection
Prevention of Neonatal HSV Infection
Reducing Acquisition of HSV-1 and HSV-2 in Late Pregnancy
Reducing Neonatal Herpes in HSV-2–Seropositive Women
Identifying Infants at Risk
Source Information
From the Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, (L.C., A.W.); and the Departments of Medicine (L.C., A.W.), Laboratory Medicine (L.C., A.W.), and Epidemiology (A.W.), University of Washington — both in Seattle.
Address reprint requests to Dr. Corey at the Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N, LE-500, Seattle, WA 98109, or at lcorey@u.washington.edu.
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |